Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Modified FOLFIRINOX (5-FU/LV, irinotecan and oxaliplatin) as second-line chemotherapy for gemcitabine-resistant or -refractory advanced pancreatic cancer
- Authors
- Lee, S. C.; Lee, K.; Bae, S. B.; Kim, Han Jo; Oh, S. Y.; Song, S. Y.; Hong, D. S.; Kim, Hyun Jung; Yoon, J.; Lim, D. H.; Lee, S. I.; Won, J. H.; Lee, N.; Kim, K.; Lee, H. W.; Lee, H. R.; Nam, E. M.; Jang, J. S.; Hwang, In Gyu; Kang, J. H.
- Issue Date
- Sep-2015
- Publisher
- ELSEVIER SCI LTD
- Citation
- EUROPEAN JOURNAL OF CANCER, v.51, pp S456 - S456
- Journal Title
- EUROPEAN JOURNAL OF CANCER
- Volume
- 51
- Start Page
- S456
- End Page
- S456
- ISSN
- 0959-8049
1879-0852
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > College of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.